AKT1 and colitis: The active compounds in EB, particularly phlorotannins such as eckol and dieckol, may exert anti-inflammatory effects through PI3K/AKT/mTOR inhibition, NF-κB modulation, and gut microbiota regulation, highlighting its potential as an alternative or complementary treatment for colitis.